Sitemap
November 08, 2023 Articles
Filter by Available Specialty
- New approaches show promise for treatment of gastroesophageal cancers
- ‘Downstream effects’ of alcohol use disorder swell in wake of COVID-19
- ‘Wander and wonder’: How to navigate your first ACR Convergence
- About one in 260 people in the United States has a coconut allergy
- ACLF with recompensated cirrhosis has ‘generally milder’ severity, better prognosis
- Aerosol gene therapy safe, heightens CFTR protein levels in cystic fibrosis
- ALIGN AR: ‘Intuitive’ TAVR system safe, effective for severe aortic regurgitation
- All things considered, is geographic atrophy treatment ready for widespread use?
- BLOG: GA patients deserve better drug adoption
- Comorbidities add treatment burdens to atopic dermatitis
- Comprehensive ophthalmologists will have meaningful role in treating geographic atrophy
- Deep learning algorithm shows utility in identifying DME
- Different risk factors for adverse outcomes in singleton, twin pregnancies
- ED visits for pediatric firearm injuries nearly doubled during COVID-19 pandemic
- Executive order directs HHS to monitor AI safety in health care
- FDA approves first renal denervation device to treat hypertension
- FDA: Lotronex, approved generics no longer require REMS to ensure benefits outweigh risks
- Geographic atrophy treatment options ignite debate on concerns, expectations
- Hooked on Primary Care with Ira P. Monka, DO, MHA, FACOFP
- Increased dose of Jeuveau corrects glabellar lines up to 6 months
- Increasing maternal BMI linked to higher risk for postpartum infection
- Investigational oral therapy increases height velocity for children with GH deficiency
- Leftover antibiotics ‘major barrier to antimicrobial stewardship’
- Lifestyle course produces 'significant and sustained results' in Appalachia
- Lumenis launches new radiofrequency device to treat dry eye inflammation
- Male patients, Black patients, rural residents more likely to die of pulmonary embolism
- Man presents with sudden onset decrease in central vision in left eye
- Melatonin may not improve sleep disturbance after TKR
- Orthofix launches new bioactive synthetic graft
- Partnership to advance therapeutic for Charcot-Marie-Tooth disease type 1a
- Preparing the right tools key to handling cataract cases with zonulopathy
- Q&A: How to address eating disorders in type 1 diabetes
- Race linked to quality, timeliness of care in adults with early-onset colorectal cancer
- Racial, ethnic disparities impact mortality rates among inborn errors of immunity
- States that restrict abortion see more foster care entries
- Study suggests documentation of alcohol use needs to improve in disadvantaged areas
- Study supports use of botulinum toxin for head tremor
- Surgeons use breast implants during double-lung transplant
- Survey shows limited uptake with new anemia drugs
- Taking a multidisciplinary approach to in-transit melanoma treatment
- Those affected by sickle cell disease willing to accept gene therapy risks
- Tirzepatide earns FDA approval for obesity treatment
- Top in endocrinology: Myths of ‘carb-phobia’; testosterone therapy has its limits
- VIDEO: Adagrasib, pembrolizumab shows ‘encouraging’ activity in KRAS G12C-mutated NSCLC
- VIDEO: Advances in fetal neurology highlighted at CNS annual meeting
- VIDEO: Amivantamab plus chemo ‘new standard of care’ in EGFR-mutated NSCLC after progression
- VIDEO: Analysis finds similar BCVA, superior CST for faricimab vs. aflibercept in DME
- VIDEO: Better visual acuity endpoints may increase earlier diagnosis of AMD
- VIDEO: Current treatment options for wet, dry AMD
- VIDEO: ERGs now ‘doctor-friendly,’ more affordable tool for visual function
- VIDEO: Lobby Talks, clinical research workshops at CNS annual meeting help advance careers
- VIDEO: Novel therapy shows clinical activity in EGFR-mutated NSCLC
- VIDEO: Promising future research in intermediate AMD, wet AMD treatments
- VIDEO: Recent approvals for geographic atrophy ‘exciting development’ in AMD
- VIDEO: Smoking cessation recommended for patients with AMD
- Watch for flashing warning lights in your practice
- XEN1101 significantly reduced monthly seizures for adults with focal-onset epilepsy